New University of Virginia School of Medicine research revealing the fingerprints of Sudden Infant Death Syndrome within blood samples could open the door to simple tests to identify babies at risk.
Former Prometheus execs raise $400M for precision immunology startup: ‘The band is back together’
After selling his last company to Merck for $10.8 billion in June, Mark McKenna couldn’t shake the feeling that he’d left the job unfinished. On Thursday,